Streetbeat News

Earnings

PAVM

PAVmed reported Q2 losses of $(0.09) per share, beating the analyst consensus estimate of $(0.19) by 52.63%. However, the company's quarterly sales of $166.00K missed the analyst consensus estimate of $520.00K by 68.08%.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 4:21 am

TGT

TSLA

VFS

Shares of Target, Nu Holdings, Hawaiian Electric, VinFast, and Tesla drew investor attention amid a challenging day for the stock market. Target is preparing to report its Q2 earnings, while Nu Holdings highlighted a 5x revenue growth in its Q2 2023 financial results. Hawaiian Electric faced scrutiny over fire risks and potential impacts on its credit quality. VinFast surged after completing its SPAC merger, and Tesla introduced two new 'standard range' versions of its Model S and X vehicles.

Portfolio Pulse from Benzinga Neuro

August 16, 2023 | 2:05 am

FLHLF

JAQC

Filament Health (OTCQB:FLHLF) has released its Q1 2023 financial results, showing a decrease in total cash and an accumulated deficit of $19.6 million. The company has expressed uncertainties about its ability to execute its business plan and continue operations without additional financing. Filament has announced its intention to list on the NASDAQ through a business combination with Jupiter Acquisition Corp. (NASDAQ:JAQC). The company has also reported progress in its drug development program, including FDA approval of two clinical studies and a global licensing agreement with NeoLumina Bioscience Inc.

Portfolio Pulse from Lara Goldstein

August 15, 2023 | 10:21 pm

FFNTF

4Front Ventures Corp. reported its Q2 2023 financial results, revealing a 1.15% YoY increase in Systemwide Pro Forma revenue to $35.2 million. The company also reported GAAP revenue of $30.7 million, up 8% from Q2 2022, and adjusted EBITDA of $2.0 million. 4Front expanded its presence in Illinois, acquired a third dispensary license, and introduced new products in Massachusetts. However, the company's shares closed 10.42% lower at $0.0851 per share.

Portfolio Pulse from Joana Scopel

August 15, 2023 | 10:15 pm

VEDU

Visionary Education Tech (NASDAQ:VEDU) reported a quarterly loss of $(0.09) per share. However, the company's sales increased by 60.67% to $8.43 million, up from $5.25 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:08 pm

DADA

Dada Nexus, a Chinese on-demand delivery and retail platform, anticipates its Q3 total net revenues to increase year-over-year by 17.6% to 26.0%.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:05 pm

DADA

Dada Nexus (NASDAQ:DADA) reported Q2 earnings of $0.00 per share, beating the analyst consensus estimate of $(0.02) by 105 percent. However, the company's quarterly sales of $401.37 million missed the analyst consensus estimate of $418.25 million by 4.04 percent.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:03 pm

MYCOF

Mydecine Innovations Group (OTC:MYCOF) has released its financial results for Q2 2023, showing a cash position of $29.987, R&D expenses of $75.417 and $181.656 for three and six months respectively, and total expenses of $1.96 million and $4.9 million for the same periods. The net loss attributable to common stockholders was $2.36 million and $8.03 million for three and six months respectively. The company's accumulated deficit was $109.117.914. Mydecine is developing psychedelic compounds for medical use, including a psilocybin-derived smoking cessation drug and short-acting chemical MDMA analogs for anxiety and pain treatment.

Portfolio Pulse from Lara Goldstein

August 15, 2023 | 9:44 pm

ARHS

CAVA

HLLY

LRN

SHCO

In Tuesday's after-market session, several consumer discretionary stocks saw significant movement. Stride (LRN), Cava Group (CAVA), Aterian (ATER), Yoshiharu Global (YOSH), Lixiang Education Hldg (LXEH), and Zapp Electric Vehicles (ZAPP) all saw gains, with Stride and Cava Group both releasing Q4 and Q2 earnings respectively. On the other hand, Arhaus (ARHS), Holley (HLLY), Soho House (SHCO), Chijet Motor Co (CJET), F45 Training Holdings (FXLV), and 17 Education & Technology (YQ) all saw declines, with Arhaus, Holley, and Soho House all releasing Q2 earnings in the past few days.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 9:32 pm

AGLE

ALZN

CING

ELOX

IMPL

KZR

LIFW

NVOS

NXL

TNON

TPST

TTOO

Several healthcare stocks experienced significant movement in Tuesday's after-market session. Gainers included Novo Integrated Sciences (NVOS), Nexalin Technology (NXL), T2 Biosystems (TTOO), MSP Recovery (LIFW), Alzamend Neuro (ALZN), and Tenon Medical (TNON). Losers included Impel Pharmaceuticals (IMPL), Tempest Therapeutics (TPST), Eloxx Pharmaceuticals (ELOX), Aeglea BioTherapeutics (AGLE), Kezar Life Sciences (KZR), and Cingulate (CING). Several companies recently released their Q2 earnings reports.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 9:32 pm